Adiponectin is released from the heart in patients with heart failure.

[1]  P. Whincup,et al.  Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. , 2007, Archives of internal medicine.

[2]  Walter Koch,et al.  Adiponectin Cardioprotection After Myocardial Ischemia/Reperfusion Involves the Reduction of Oxidative/Nitrative Stress , 2007, Circulation.

[3]  P. Arner,et al.  Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue , 2007, Diabetologia.

[4]  Y. Saitoh,et al.  Transcardiac adiponectin gradient is independently related to endothelial vasomotor function in large and resistance coronary arteries in humans. , 2006, American journal of physiology. Heart and circulatory physiology.

[5]  M. Kawakami,et al.  Association of Hyperadiponectinemia With Severity of Ventricular Dysfunction in Congestive Heart Failure , 2006 .

[6]  Kohjiro Ueki,et al.  Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. , 2006, The Journal of clinical investigation.

[7]  K. Walsh,et al.  Cardioprotection by adiponectin. , 2006, Trends in cardiovascular medicine.

[8]  K. Node,et al.  Comparison of Serum High–Molecular Weight (HMW) Adiponectin With Total Adiponectin Concentrations in Type 2 Diabetic Patients With Coronary Artery Disease Using a Novel Enzyme-Linked Immunosorbent Assay to Detect HMW Adiponectin , 2006, Diabetes.

[9]  Takamitsu Nakamura,et al.  Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart. , 2006, American journal of physiology. Heart and circulatory physiology.

[10]  Y. Sharabi,et al.  Circulating adiponectin concentrations in patients with congestive heart failure , 2006, Heart.

[11]  Domenico Corradi,et al.  Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart , 2005, Nature Clinical Practice Cardiovascular Medicine.

[12]  R. Piñeiro,et al.  Adiponectin is synthesized and secreted by human and murine cardiomyocytes , 2005, FEBS letters.

[13]  Jan Frystyk,et al.  Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure , 2005, Circulation.

[14]  S. Kihara,et al.  Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2–dependent mechanisms , 2005, Nature Medicine.

[15]  J. Burnett,et al.  The prognostic value of N-terminal proB-type natriuretic peptide , 2005, Nature Clinical Practice Cardiovascular Medicine.

[16]  F. Leonetti,et al.  Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. , 2005, Cytokine.

[17]  D. Corradi,et al.  The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[18]  Takamitsu Nakamura,et al.  Correlation of plasma concentrations of B-type natriuretic peptide with infarct size quantified by tomographic thallium-201 myocardial scintigraphy in asymptomatic patients with previous myocardial infarction. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[19]  S. Kihara,et al.  Adiponectin and Metabolic Syndrome , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[20]  S. Kihara,et al.  Association of Hypoadiponectinemia With Coronary Artery Disease in Men , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[21]  H. Matsuo Discovery of a natriuretic peptide family and their clinical application. , 2001, Canadian journal of physiology and pharmacology.

[22]  J. Takasu,et al.  Pericardial fat accumulation in men as a risk factor for coronary artery disease. , 2001, Atherosclerosis.

[23]  K. Kugiyama,et al.  Localization and Mechanism of Secretion of B‐Type Natriuretic Peptide in Comparison With Those of A‐Type Natriuretic Peptide in Normal Subjects and Patients With Heart Failure , 1994, Circulation.

[24]  D. Levy,et al.  Survival After the Onset of Congestive Heart Failure in Framingham Heart Study Subjects , 1993, Circulation.

[25]  G. Serio,et al.  Is adipose tissue a normal component of the myocardium? , 1989, European heart journal.

[26]  A. di Lenarda,et al.  Epidemiology of dilated cardiomyopathy. A prospective post-mortem study of 5252 necropsies. The Heart Muscle Disease Study Group. , 1997, European heart journal.

[27]  G. Sinagra,et al.  Epidemiology of dilated cardiomyopathy , 1997 .